New York, NY -- (SBWIRE) -- 01/23/2014 -- Stock Professors is committed to provide its readers with best analytics on hot penny stocks. Our team of stock trading professional's mission is to analyze, track and rate the top penny stocks to buy in the market today. We realize how tough it is for the ordinary investor to make money in today’s volatile stock market. Some, probably like you turn to penny stocks in order to make huge gains on relatively little capital. Today’s hot Stocks to watch are: Arca Biopharma Inc (NASDAQ:ABIO), Tranzbyte Corp (OTCMKTS:ERBB), ReneSola Ltd. (ADR) (NYSE:SOL), Cree, Inc (NASDAQ:CREE)
Arca Biopharma Inc (NASDAQ:ABIO) showed a volume of 1.95 million shares by the end of last trade whereas the average volume of the stock remained 1.46 million shares. The stock opened the session at $2.12 but then moved to $2.16. At that price, the stock showed a positive performance of 1.89%. ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company's principal focus is developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA's lead product candidate is Gencaro TM (bucindolol hydrochloride),
Will ABIO Continue To Move Higher? Find Out Here
Tranzbyte Corp (OTCMKTS:ERBB) opened the session at $0.01 and closed the session at $0.0073. The stock showed a negative performance of -3.95% in previous trading session. Traded with volume of 82.67 million shares in the prior session and the average volume of the stock remained 130.82 million shares. The Tranzbyte Corporation is a driving force behind Altitude Organic Corporation, One Bode, The YO! Debit Card, and ProximaRF. Altitude Organic Corporation is a medical marijuana dispensary brand. It has developed retailing,
Has ERBB Found The Bottom And Ready To Gain Momentum? Find Out Here
ReneSola Ltd. (ADR) (NYSE:SOL) opened the session at $3.83 and closed the session at $2.91. The stock showed a positive performance of 2.36% in previous trading session. The beta of the stock remained 3.17. ReneSola Ltd (ReneSola), incorporated on March 17, 2006, is a global manufacturer of solar wafers and producer of solar power products based in the People's Republic of China. ReneSola possess a global network of suppliers and customers that includes some of the global manufacturers of solar cells and modules.
Why Should Investors Buy SOL After The Recent Gain? Just Go Here and Find Out
Cree, Inc (NASDAQ:CREE) the stock advanced 7.16% and finished the session at $67.33. Traded with volume of 6.43 million shares in the prior session and the average volume of the stock remained 1.93 million shares. The beta of the stock remained 1.11. Cree, Inc. (Cree) develops and manufactures semiconductor materials and devices primarily based on silicon carbide (SiC), gallium nitride (GaN) and related compounds. It focuses its expertise in SiC and GaN on light emitting diode (LED) products.
Will CREE Continue To Move Higher ? Find Out Here
About Stock Professors:
We realize how tough it is for the ordinary investor to make money in today’s volatile stock market. That is why we offer penny stocks to watch and FREE stock picks to all our subscribers. We focus on undervalued and undiscovered penny stocks which are poised for not just short term but also long term growth. StockProfessors.com searches the market to bring you the best penny stocks. So, don’t wait any longer and subscribe to our FREE newsletter to get the hot penny stock picks delivered right in your email inbox!
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances.
The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://www.stockprofessors.com/disclaimer/